FDA Adverse Event Malfunction Summary report: N

LIBERTÉ?

MDR report key: 4825118 · Received June 8, 2015

Report

Report Number
2134265-2015-03544
Event Type
Malfunction
Date Received
June 8, 2015
Date of Event
February 1, 2015
Report Date
May 13, 2015
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
MAF
PMA / PMN Number
P040016
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(6). (B)(4). DEVICE EVALUATED BY MFR.: THE DEVICE HAS NOT BEEN RECEIVED FOR ANALYSIS. UPON RECEIPT AND COMPLETION OF THE FAILURE ANALYSIS OF THE COMPLAINT DEVICE, IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Additional Manufacturer Narrative · 1

BRAND NAME CORRECTED FROM TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM TO LIBERTÉ¿. COMMON DEVICE NAME CORRECTED FROM CORONARY DRUG-ELUTING STENT TO STENT, CORONARY. PRODUCT CODE CORRECTED FROM NIQ TO MAF. (B)(4). UPN CORRECTED FROM UNK433 TO H7493893820350. (B)(4).

Description of Event or Problem · 1

IT WAS FURTHER REPORTED THAT THE LOCATION OF THE DAMAGE WAS <15CM FROM THE HUB, AND THAT THE SHAFT WAS NOT COMPLETELY BROKEN AND SEPARATED.

Description of Event or Problem · 1

IT WAS REPORTED THAT SHAFT BREAK OCCURRED. VASCULAR ACCESS WAS OBTAINED VIA THE FEMORAL ARTERY. THE 70% STENOSED, DE NOVO TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND NON-CALCIFIED TARGET VESSEL. FOLLOWING PREDILATION, A TAXUS LIBERTE STENT WAS ADVANCED TO TREAT THE LESION; HOWEVER SIGNIFICANT RESISTANCE WAS MET AND THE SHAFT BROKE. THE PROCEDURE WAS COMPLETED WITH A DIFFERENCE DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
367929 LIBERTÉ? STENT, CORONARY MAF BOSTON SCIENTIFIC - MAPLE GROVE H7493893820350 0015231975

Patients

Seq Age Sex Outcome Treatment
1